Alleviation of the peripheral hemodynamic effects of dexmedetomidine by the calcium channel blocker isradipine

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 3, 1997, Pages 364-370

  Roekaerts, P M H J ^a   Lawrence, C J ^a   Prinzen, F W ^b   De Lange, S ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alpha2 adrenergic agonists; Calcium channel blockers; Cardiac function; Dexmedetomidine; Isradipine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; DEXMEDETOMIDINE; ISRADIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; HEART FUNCTION; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; SEDATION; VASOCONSTRICTION; VASODILATATION;

EID: 0030894003     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04700.x     Document Type: Article

References (34)

1. 2-adrenoreceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991: 74: 581-605.
2. Kobinger W. Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 1978: 81: 39-100.
3. 2-adrenoreceptor mediated vasoconstriction of large and small canine arteries in vivo. J Cardiovasc Pharmacol 1984: 6: 961-968.
4. Fleckenstein-Grun G, Frey M, Fleckenstein A. Calcium antagonists: mechanisms and therapeutic uses. TIPS 1984: 5: 283-287.
5. 2-adrenoreceptor activation is induced by an influx of extracellular calcium. Eur J Pharrnacol 1981: 69: 205-208.
6. 2-adrenoreceptors. Can J Physiol Pharmacol 1986: 65: 1649-1657.
7. Bari F, Horvath G, Benedek G. Dexmedetomidine-induced decrease in cerebral blood flow is attenuated by verapamil in rats: a laser Doppler study. Can J Anaesth 1993: 40: 747-754.
8. Bloor BC, Frankland M, Alper G, Raybould D, Weitz J, Shurtliff M. Hemodynamic and sedative effects of dexmedetomidine in dog. J Pharmacol Exp Ther 1992: 263: 690-697.
9. Egerton K, Van den Berg EK, Dehmer GJ. Acute hemodynamic effects of intravenous isradipine. Am J Cardiol 1988: 61: 1102-1105.
10. Mauser M, Voelker W, Karsch K, Seipel L. PN 200-110, a calcium antagonist with less negative inotropic properties compared to nifedipine. Eur Heart J 1987: 8 (suppl): 170.
11. Hoppeler HH, Hess OM, Hug R, Turina J, Krayenbuhl HP. Effect of isradipine on left ventricular relaxation and diastolic filling. J Cardiovasc Pharmacol 1990: 15 (suppl): S79-S83.
12. Scheinin H, Virtanen R, Scheinin M. Alpha2-adrenoreceptor agonists decrease free 3-methoxy-4-hydroxyphenylglycol in rat cerebrospinal fluid. Eur J Pharmacol 1986: 123: 115-121.
13. Flacke WE, Flacke JW, Bloor BC, McIntee DF, Sagan M. Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog. J Cardiothorac Vase Anesth 1993: 7: 41-49.
14. 2-adrenergic agonist, in halothane-anesthetized dogs. Anesth Analg 1988: 67: 611-615.
15. Roekaerts PMHJ, Prinzen FW, De Lange S. Coronary vascular effects of dexmedetomidine during reactive hyperemia in the anesthetized dog. J Cardiothorac Vase Anesth 1996: 10: 619-625.
16. Roekaerts PMHJ, Prinzen FW, de Lange S. Beneficial effects of dexmedetomidine on ischaemic myocardium of anaesthetized dogs. Br J Anaesth 1996: 77: 427-429.
17. 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res Rev 1984: 7: 69-101.
18. Isaac L. Clonidine in the central nervous system: site and mechanism of hypertensive action. J Cardiovasc Pharmacol 1980: 2: S5-S19.
19. 2-adrenergic stimulation with UK 14,304-18 on the heart and peripheral circulation of intact dogs. J Cardiovasc Pharmacol 1985: 7: 1055-1064.
20. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. Anesthesiology 1992: 77: 1134-1142.
21. 2-adrenergic agonist, in autonomically dervervated dogs. J Cardiovasc Pharmacol 1990: 16: 616-623.
22. Roekaerts PMHJ, Prinzen FW, Willigers HMM, de Lange S. The effects of alpha adrenergic stimulation with mivazerol on myocardial blood flow and function during coronary artery stenosis in anesthetized dogs. Ancsth Analg 1996: 82: 702-711.
23. Flacke WE, Flacke JW, Blow KD, McIntee DF, Bloor BC. Effect of dexmedetomidine, an alpha2-adrenergic agonist, in the isolated heart. J Cardiothorac Vasc Anesth 1992: 6: 418-423.
24. Housmans PR. Effect of dexmedetomidine on contractility, relaxation, and intracellular calcium transients in isolated myocardium. Anesthesiology 1990: 73: 919-922.
25. 2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology 1991: 75: 499-511.
26. Proctor LT, Schmeling WT, Roerig D, Kampine JP, Warltier DC. Oral dexmedetomidine attenuates hemodynamioc responses during emergence from general anesthesia in chronically instrumented dogs. Anesthesiology 1991: 74: 108-114.
27. Lawrence CJ, Lestrade A, Chan E, de Lange S. Comparative study of isradipine and sodium nitroprusside in the control of hypertension in patients following coronary artery-by-pass surgery. Acta Anaesthesiol Scand 1993: 37 (suppl): 48-52.
28. Braunwald E. Mechanism of action of calcium channel blocking agents. N Engl J Med 1982: 307: 1618-1627.
29. Vaghy PL, Willaims JS, Schwartz A. Receptor pharmacology of calcium entry blocking drugs. Am J Cardiol 1987: 59: 9A-17A.
30. Timmermans PBMWM, Thoolen MJMC, De Jonge A, Wilffert B, Van Zwieten PA. Calcium entry and alpha-adrenoreceptor-induced vasoconstriction in vivo and in vitro. In: Refsum H, Mjos OD, eds. Alpha-adrenoreceptor blockers in cardiovascular diseases. London and New York: Churchill Livingstone, 1985: 30-50.
31. Horvath G, Szikszay M, Benedek G. Calcium channels are involved in the hypnotic-anesthetic action of dexmedetomidine in rats. Anesth Analg 1992: 74: 884-888.
32. Jalonen J, Halkola L, Kuttila K, Perttila J, Rajalin A, Savunen T et al. Effects of dexmedetomidine on coronary hemodynamics and myocardial oxygen balance. J Cardiothorac Vase Anesth 1995: 9: 519-524.
33. Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993: 78: 813-820.
34. Talke P, Li J, Jain U, Leung J, Drasner K, Hollenberg M et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology 1995: 82: 620-633.